featured
Thalidomide Improves Prevention of Delayed Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Thalidomide in Preventing Delayed Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase III Trial (CLOG1302 study)
J. Clin. Oncol 2017 Aug 30;[EPub Ahead of Print], L Zhang, X Qu, Y Teng, J Shi, P Yu, T Sun, J Wang, Z Zhu, X Zhang, M Zhao, J Liu, B Jin, Y Luo, Z Teng, Y Dong, F Wen, Y An, C Yuan, T Chen, L Zhou, Y Chen, J Zhang, Z Wang, J Qu, F Jin, J Zhang, X Jin, X Xie, J Wang, L Man, L Fu, Y LiuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.